Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours

Histopathology

Volumn 59, Issue 6, 2011, Pages 1071-1080

  Pantaleo, Maria A ^a,b   Astolfi, Annalisa ^b   Nannini, Margherita ^a   Ceccarelli, Claudio ^a   Formica, Serena ^b   Santini, Donatella ^a   Heinrich, Michael C ^c   Corless, Christopher ^c   Dei Tos, Angelo Paolo ^d   Paterini, Paola ^b   Catena, Fausto ^a   Maleddu, Alessandra ^a   Saponara, Maristella ^a   di Battista, Monica ^a   Biasco, Guido ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d General Hospital of Treviso   (Italy)

Author keywords

Gene expression profiling; GIST; ICC; ICC mature; ICC precursor; IGF1R; KIT; PDGFRA

Indexed keywords

BIOLOGICAL MARKER; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CLINICAL ARTICLE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CELL OF CAJAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DNA MUTATIONAL ANALYSIS; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CELLS OF CAJAL; MICE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; STEM CELL FACTOR; TUMOR MARKERS, BIOLOGICAL;

MURINAE;

EID: 84855937861     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04071.x     Document Type: Article

References (30)

1. Streutker CJ, Huizinga JD, Driman DK, Riddell RH. Interstitial cells of Cajal in health and diseases. Part II: ICC and gastrointestinal stromal tumors. Histopathology 2007; 50; 190-202.
2. Hirota S, Isozaki K, Moriyama Y et al. Gain of function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279; 577-580.
3. Lux ML, Rubin BP, Biase TL et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am. J. Pathol. 2000; 156; 791-795.
4. Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumours. N. Engl. J. Med. 2002; 347; 472-480.
5. Demetri GD, van Oosteroom AT, Garrett CR et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 2006; 368; 1329-1338.
6. Janewy KA, Pappo AS. Pediatric gastrointestinal stromal tumor. Hematol. Oncol. Clin. North Am. 2009; 23; 15-34.
7. Agaram NP, Laquaglia MP, Ustun B et al. Molecular characterization of pediatric gastrointestinal stromal tumors. Clin. Cancer Res. 2008; 14; 3204-3215.
8. Heinrich MC, Corless CL, Demetri GD et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J. Clin. Oncol. 2003; 21; 4342-4349.
9. Heinrich MC, Corless CL, Blanke CD et al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J. Clin. Oncol. 2006; 24; 4764-4774.
10. Pantaleo MA, Astolfi A, Di Battista M et al. Insulin-like growth factor 1 receptor (IGF1r) expression in wild-type GIST: a potential novel therapeutic target. Int. J. Cancer 2009; 125; 2991-2994.
11. Tarn C, Rink L, Merkel E et al. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc. Natl Acad. Sci. USA 2008; 105; 8387-8392.
12. Janeway KA, Zhu MJ, Barretina J, Perez-Atayde A, Demetri GD, Fletcher JA. Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification. Int. J. Cancer 2010; 27; 2718-2722.
13. Lorincz A, Redelman D, Horváth VJ, Bardsley MR, Chen H, Ordög T. Progenitors of interstitial cells of Cajal in the postnatal murine stomach. Gastroenterology 2008; 134; 1083-1093.
14. Huizinga JD, White EJ. Progenitors cells of interstitial cells of Cajal: on the road to tissue repair. Gastroenterology 2008; 134; 1252-1253.
15. Robinson TL, Sircar K, Hewlett BR, Chorneyko K, Riddell RH, Huizinga JD. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal. Am. J. Pathol. 2000; 156; 1157-1163.
16. Chen H, Ordög T, Chen J et al. Differential gene expression in functional classes of interstitial cells of Cajal in murine small intestine. Physiol. Genomics 2007; 31; 492-509.
17. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004; 3; Article 3, DOI: 10.2202/1544-6115.1027.
18. Scotlandi K, Picci P. Targeting insulin-like growth factor 1 receptor in sarcomas. Curr. Opin. Oncol. 2008; 20; 419-427.
19. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res. 2005; 65; 4633-4644.
20. Rocchi A, Manara MC, Sciandra M et al. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis. J. Clin. Invest. 2010; 120; 668-680.
21. Cutcliffe C, Kersey D, Huang CC, Zeng Y, Walterhouse D, Perlman EJ. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin. Cancer Res. 2005; 11; 7986-7994.
22. Agaimy A, Wünsch PH. Sporadic Cajal cell hyperplasia is common in resection specimens for distal oesophageal carcinoma. A retrospective review of 77 consecutive surgical resection specimens. Virchows Arch. 2006; 448; 288-294.
23. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am. J. Pathol. 2002; 160; 1567-1572.
24. Agaimy A, Wünsch PH, Hofstaedter F et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am. J. Surg. Pathol. 2007; 31; 113-120.
25. Agaimy A, Dirnhofer S, Wünsch PH, Terracciano LM, Tornillo L, Bihl MP. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am. J. Surg. Pathol. 2008; 32; 1553-1559.
26. Gasparotto D, Rossi S, Bearzi I et al. Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entity. Clin. Cancer Res. 2008; 14; 5715-5721.
27. Haller F, Schulten HJ, Armbrust T, Langer C, Gunawan B, Füzesi L. Multicentric sporadic gastrointestinal stromal tumors (GISTs) of the stomach with distinct clonal origin: differential diagnosis to familial and syndromal GIST variants and peritoneal metastasis. Am. J. Surg. Pathol. 2007; 31; 933-937.
28. Kang DY, Park CK, Choi JS et al. Multiple gastrointestinal stromal tumors: clinicopathologic and genetic analysis of 12 cases. Am. J. Surg. Pathol. 2007; 31; 224-232.
29. Ogasawara N, Tsukamoto T, Inada K et al. Frequent c-Kit gene mutations not only in gastrointestinal stromal tumors but also in interstitial cells of Cajal in surrounding normal mucosa. Cancer Lett. 2005; 230; 199-210.
30. Rossi S, Gasparotto D, Toffolati L et al. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Am. J. Surg. Pathol. 2010; 34; 1480-1491.